𝛼SK or Searchbullish
IPO Databook: GT Biopharma (GTBP US) - Oct 2026
84 Views11 Oct 2026 10:00
SUMMARY
- GT Biopharma, Inc. is a clinical stage biopharmaceutical company developing and commercializing novel immuno-oncology products using proprietary TriKE® and Dual Targeting TriKE® platforms.
- The company is a clinical stage biopharmaceutical company focused on novel immuno-oncology products, utilizing proprietary TriKE® and Dual Targeting TriKE® platforms.
- The company faces substantial doubt about its ability to continue as a going concern, as noted in its FY2025 independent auditor's report.
This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- IPO Databook: GT Biopharma (GTBP US) - Oct 202611 Oct 2026
x